Abstract
In agreement with worldwide initiatives to solve this pain by pharmaceutical companies such as Novartis and AstraZeneca, we aim to promote an alternative therapy for hypercholesterolemia. During phase 1 of this project, we developed peptide analogues (tELH6A and tELH6A) in Homologous modeling to domain A of growth factor precursor homology epidermal (EGF-A) of the low-density lipoprotein …